News
Scientists in Shanghai have made a breakthrough in protein design by leveraging artificial intelligence, establishing the ...
A new set of artificial intelligence models could make protein sequencing even more powerful for better understanding cell biology and diseases.
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Shanghai scientists have made breakthrough in protein design by leveraging artificial intelligence, establishing the world's ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
On the 17th, Galux disclosed six novel antibody candidate substances designed with its protein design AI, 'Galux Design', on the preprint site bioRxiv. The antibodies bind to the proteins PD-L1 ...
Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results